Your browser doesn't support javascript.
loading
ABC transporters: human disease and pharmacotherapeutic potential.
Moore, Jonathan M; Bell, Eric L; Hughes, Robert O; Garfield, Alastair S.
Afiliação
  • Moore JM; Rectify Pharmaceuticals, Cambridge, MA, USA. Electronic address: moore@rectifypharma.com.
  • Bell EL; Rectify Pharmaceuticals, Cambridge, MA, USA.
  • Hughes RO; Rectify Pharmaceuticals, Cambridge, MA, USA.
  • Garfield AS; Rectify Pharmaceuticals, Cambridge, MA, USA. Electronic address: agarfield@rectifypharma.com.
Trends Mol Med ; 29(2): 152-172, 2023 02.
Article em En | MEDLINE | ID: mdl-36503994
ABSTRACT
Adenosine triphosphate (ATP)-binding cassette (ABC) transporters are a 48-member superfamily of membrane proteins that actively transport a variety of biological substrates across lipid membranes. Their functional diversity defines an expansive involvement in myriad aspects of human biology. At least 21 ABC transporters underlie rare monogenic disorders, with even more implicated in the predisposition to and symptomology of common and complex diseases. Such broad (patho)physiological relevance places this class of proteins at the intersection of disease causation and therapeutic potential, underlining them as promising targets for drug discovery, as exemplified by the transformative CFTR (ABCC7) modulator therapies for cystic fibrosis. This review will explore the growing relevance of ABC transporters to human disease and their potential as small-molecule drug targets.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transportadores de Cassetes de Ligação de ATP / Fibrose Cística Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transportadores de Cassetes de Ligação de ATP / Fibrose Cística Idioma: En Ano de publicação: 2023 Tipo de documento: Article